ArticleMissouri medicine
Treating our youngest patients: psychotropic medications in early childhood.
Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- Early antipsychotic treatment in juvenile rats elicits long-term alterations to the adult serotonin receptors.Neuropsychiatric disease and treatment · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past several decades there have been multiple studies indicating that infants, toddlers and preschoolers who develop emotional and behavioral problems may not simply outgrow their problems. Early intervention is ideal, and may help to maximize long-term functioning. When other interventions fail or do not fully address the symptoms, psychotropic medications can be very helpful, even in the preschool years. With limited scientific research in this population, the use of psychotropic medications in very young children can be challenging. The judicious use of these agents in this population will be discussed, including weighing the risks and benefits of prescribing to these most vulnerable patients.
Indexed as
Identifiers
25011342PMC6179566W2405144815What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.